Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a common subtype of non-Hodgkin’s lymphoma (NHL). We assessed serum biomarkers to identify patients with DLBCL and healthy controls, as well as prognosis-related paired pre- and post-R-CHOP therapy effect of patients with DLBCL. METHODS: Serum sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Che, Yi-Qun, Wang, Di, Liu, Peng, Zhang, Yue, Luo, Yang, Liu, Hui-Ying, Shen, Di, Cui, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797442/
https://www.ncbi.nlm.nih.gov/pubmed/35117818
http://dx.doi.org/10.21037/tcr-19-2809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797442/
https://www.ncbi.nlm.nih.gov/pubmed/35117818
http://dx.doi.org/10.21037/tcr-19-2809

Ejemplares similares